Common Stock, Shares, Outstanding of Serina Therapeutics, Inc. from 31 Dec 2017 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Serina Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2017 to 30 Sep 2025.
  • Serina Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 10,543,000, a 19% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Serina Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 10,543,000 +1,651,000 +19% 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 10,145,000 +1,353,246 +15% 30 Jun 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 9,932,000 +1,518,111 +18% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 9,422,000 +7,012,000 +291% 31 Dec 2024 10-Q 13 Nov 2025 2025 Q3
Q3 2024 8,892,000 -29,059,000 -77% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 8,791,754 -29,159,507 -77% 30 Jun 2024 10-Q 09 Aug 2024 2024 Q2
Q1 2024 8,413,889 -29,537,372 -78% 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 2,410,000 +1,331,000 +123% 31 Dec 2023 10-K 24 Mar 2025 2024 FY
Q3 2023 37,951,000 +3,848 +0.01% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 37,951,261 +6,153 +0.02% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 37,951,261 +8,197 +0.02% 31 Mar 2023 10-Q 12 May 2023 2023 Q1
Q4 2022 1,079,000 -36,862,220 -97% 31 Dec 2022 10-K 22 Mar 2024 2023 FY
Q3 2022 37,947,152 +7,976 +0.02% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 37,945,108 +7,976 +0.02% 30 Jun 2022 10-Q 12 Aug 2022 2022 Q2
Q1 2022 37,943,064 +8,064 +0.02% 31 Mar 2022 10-Q 13 May 2022 2022 Q1
Q4 2021 37,941,220 +250,173 +0.66% 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q3 2021 37,939,176 +250,176 +0.66% 30 Sep 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 37,937,132 +279,132 +0.74% 30 Jun 2021 10-Q 13 Aug 2021 2021 Q2
Q1 2021 37,935,000 +279,000 +0.74% 31 Mar 2021 10-Q 17 May 2021 2021 Q1
Q4 2020 37,691,047 +42,047 +0.11% 31 Dec 2020 10-K 29 Mar 2022 2021 FY
Q3 2020 37,689,000 +40,000 +0.11% 30 Sep 2020 10-Q 16 Nov 2020 2020 Q3
Q2 2020 37,658,000 +28,000 +0.07% 30 Jun 2020 10-Q 14 Aug 2020 2020 Q2
Q1 2020 37,656,000 +26,000 +0.07% 31 Mar 2020 10-Q 14 May 2020 2020 Q1
Q4 2019 37,649,000 +1,819,000 +5.1% 31 Dec 2019 10-K 31 Mar 2021 2020 FY
Q3 2019 37,649,000 30 Sep 2019 10-Q 14 Nov 2019 2019 Q3
Q2 2019 37,630,000 30 Jun 2019 10-Q 14 Aug 2019 2019 Q2
Q1 2019 37,630,000 31 Mar 2019 10-Q 15 May 2019 2019 Q1
Q4 2018 35,830,000 +2,080,000 +6.2% 31 Dec 2018 10-K/A 31 Mar 2020 2019 FY
Q4 2017 33,750,000 31 Dec 2017 10-K 01 Apr 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.